Design of the Dutch prevention of influenza, surveillance and management (PRISMA) study.

[1]  W. Stalman,et al.  Improving influenza vaccination coverage among high-risk patients: a role for computer-supported prevention strategy? , 1998, Family practice.

[2]  K. Nicholson,et al.  Respiratory viruses and exacerbations of asthma in adults. , 1993, BMJ.

[3]  D. H. Williams,et al.  What are the complications of influenza and can they be prevented? Experience from the 1989 epidemic of H3N2 influenza A in general practice. , 1993, BMJ.

[4]  H. Sacks,et al.  The Efficacy of Influenza Vaccine in Elderly Persons , 1995, Annals of Internal Medicine.

[5]  W. Barker,et al.  Excess pneumonia and influenza associated hospitalization during influenza epidemics in the United States, 1970-78. , 1986, American journal of public health.

[6]  K. Nicholson.  Impact of influenza and respiratory syncytial virus on mortality in England and Wales from January 1975 to December 1990 , 1996, Epidemiology and Infection.

[7]  M. Drummond,et al.  The costs and benefits of preventing influenza in Ontario's elderly. , 1988, Canadian journal of public health = Revue canadienne de sante publique.

[8]  J C Jager,et al.  Economic evaluation of influenza vaccination. Assessment for The Netherlands. , 1999, PharmacoEconomics.

[9]  N. Masurel,et al.  Influenza-related excess mortality in the Netherlands 1989/90 , 1990, The Lancet.

[10]  Implementing the Dutch College of General Practitioner's guidelines for influenza vaccination: an intervention study. , 1997, The British journal of general practice : the journal of the Royal College of General Practitioners.

[11]  W. Stalman,et al.  Is immunising all patients with chronic lung disease in the community against influenza cost effective? Evidence from a general practice based clinical prospective cohort study in Utrecht, The Netherlands. , 1998, Journal of epidemiology and community health.

[12]  J L Nielsen,et al.  [Influenza vaccination]. , 1997, Ugeskrift for laeger.

[13]  A. Hoes,et al.  Prognostic factors for influenza-associated hospitalization and death during an epidemic , 2001, Epidemiology and Infection.

[14]  Helliwell Be,et al.  The costs and benefits of preventing influenza in Ontario's elderly. , 1988 .

[15]  A. Hoes,et al.  Effectiveness of a co-ordinated nation-wide programme to improve influenza immunisation rates in The Netherlands. , 2000, Scandinavian journal of primary health care.

[16]  M. Logar,et al.  Microbial Aetiology of Community-Acquired Pneumonia in Hospitalised Patients , 1999, European Journal of Clinical Microbiology and Infectious Diseases.

[17]  N. Cox,et al.  Prevention and control of influenza , 1999, The Lancet.

[18]  R. Goodman,et al.  Prevention and control of type A influenza infections in nursing homes. Benefits and costs of four approaches using vaccination and amantadine. , 1987, Annals of internal medicine.

[19]  F. Hayden,et al.  The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children. , 1998, The New England journal of medicine.

[20]  M. Degré.  [Prevention and treatment of influenza]. , 1992, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.

[21]  T. Raghunathan,et al.  Influenza vaccination and the risk of primary cardiac arrest. , 2000, American journal of epidemiology.

[22]  E. D. Coleman,et al.  Viral respiratory tract infection and exacerbations of asthma in adult patients. , 1988, Thorax.

[23]  P. Fallis.  Influenza season. , 1994, The Canadian journal of infection control : the official journal of the Community & Hospital Infection Control Association-Canada = Revue canadienne de prevention des infections.

[24]  K. Nichol,et al.  The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. , 1994, The New England journal of medicine.

[25]  A. Hoes,et al.  Clinical effectiveness of conventional influenza vaccination in asthmatic children , 2002, Epidemiology and Infection.

[26]  D. Fleming,et al.  Study of the effectiveness of influenza vaccination in the elderly in the epidemic of 1989–90 using a general practice database , 1995, Epidemiology and Infection.

[27]  R. Couch,et al.  Impact of respiratory virus infections on persons with chronic underlying conditions. , 2000, JAMA.

[28]  A. Monto,et al.  Influenza vaccine effectiveness in preventing hospitalization among the elderly during influenza type A and type B seasons. , 1995, International journal of epidemiology.

[29]  K. Nichol,et al.  Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens. , 1998, Archives of internal medicine.

[30]  J. C. Bell,et al.  Influenza vaccination. , 1983, JAMA.

[31]  A. Osterhaus,et al.  [Influenza season 1999/2000 and vaccine composition for the season 2000/01]. , 2000, Nederlands tijdschrift voor geneeskunde.

[32]  A. Kendal,et al.  Impact of influenza epidemics on mortality in the United States from October 1972 to May 1985. , 1987, American journal of public health.

[33]  H. Jick,et al.  Acute respiratory-tract infections and risk of first-time acute myocardial infarction , 1998, The Lancet.

[34]  M. Naghavi,et al.  Association of Influenza Vaccination and Reduced Risk of Recurrent Myocardial Infarction , 2000, Circulation.

[35]  L S Geiss,et al.  Impact of diabetes mellitus on mortality associated with pneumonia and influenza among non-Hispanic black and white US adults. , 1999, American journal of public health.

[36]  M. Hornbrook,et al.  Influenza Vaccination Programs for Elderly Persons: Cost-Effectiveness in a Health Maintenance Organization , 1994, Annals of Internal Medicine.

[37]  R. Grol,et al.  Negen jaar influenzavaccinatie in de huisartspraktijk , 2000 .